U.S. awards contract to produce swabs for point-of-care test

by on

U.S. awards contract to produce swabs for point-of-care test
tjordan_drupal
Nov 24, 2020

The departments of Health and Human Services and Defense yesterday announced an $11.6 million contract to domestically produce more nasal swabs for the Cue Health molecular testing system, which detects the COVID-19 virus in about 20 minutes at the point of care.

The contract will allow Puritan Medical Products Company to expand domestic production capacity to 3 million per month by March 2021, the agencies said. HHS recently distributed 27,000 Cue Health test kits to Alaska, Florida, Louisiana, New Jersey and Texas for a pilot test. The Food and Drug Administration has authorized emergency use of the testing system in patient care settings operating under a CLIA certificate of waiver, compliance or accreditation.

Headline

U.S. awards contract to produce swabs for point-of-care test
tjordan_drupal
Nov 24, 2020

The departments of Health and Human Services and Defense yesterday announced an $11.6 million contract to domestically produce more nasal swabs for the Cue Health molecular testing system, which detects the COVID-19 virus in about 20 minutes at the point of care.

The contract will allow Puritan Medical Products Company to expand domestic production capacity to 3 million per month by March 2021, the agencies said. HHS recently distributed 27,000 Cue Health test kits to Alaska, Florida, Louisiana, New Jersey and Texas for a pilot test. The Food and Drug Administration has authorized emergency use of the testing system in patient care settings operating under a CLIA certificate of waiver, compliance or accreditation.

Novel Coronavirus (SARS-CoV-2/COVID-19)

Headline

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: